Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the 25th Annual ROTH Conference being held at The Ritz-Carlton Hotel in Laguna Niguel, California. The Company presentation is on Wednesday, March 20, 2013, at 11:00 AM PT.
